BDBM165340 US8168651, Compound TABLE 16.6::US9062043, Table 13, Compound 6::US9062043, Table 20b, Compound 4

SMILES COc1cccc(Nc2nc3cc(ccc3c3cnccc23)C(O)=O)c1

InChI Key InChIKey=ORFKRAIKKNYTFV-UHFFFAOYSA-N

Data  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 165340   

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 4nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 4nMpH: 7.2Assay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 7nMAssay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2023
Entry Details
US Patent

TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 7nMpH: 7.2Assay Description:Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent

TargetCasein kinase II subunit alpha'(Human)
University of North Carolina At Chapel Hill

Curated by ChEMBL
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 340nMAssay Description:Inhibition of C-terminal Nano-Luc fused human CK2alpha' expressed in HEK293 cells using NanoBRET NanoGlo substrate in presence of tracer K5 by NanoBR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of C-terminal Nano-Luc fused human CK2alpha expressed in HEK293 cells using NanoBRET NanoGlo substrate in presence of tracer K10 by NanoBR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/22/2024
Entry Details
PubMed
TargetCasein kinase II subunit alpha(Human)
Cylene Pharmaceuticals

US Patent
LigandPNGBDBM165340(US9062043, Table 20b, Compound 4 | US9062043, Tabl...)
Affinity DataIC50: 2.33E+3nMpH: 7.4Assay Description:The human leukemia Jurkat T-cell line was maintained in RPMI 1640 (Cambrex) supplemented with 10% fetal calf serum and 50 ng/ml Geutamycin. Before tr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/22/2016
Entry Details
US Patent